PharmaShots | Incisive News in 3 Shots

Subscribe Now

Multiple Cancers

Celgene Signs an Option to License Agreement with Immatics to Develop Novel Adoptive Cell Therapies Targeting Multiple Cancers

Celgene Signs an Option to License Agreement with Immatics to Develop Novel Adoptive Cell Therapies Targeting Multiple Cancers

August 29, 2019

Celgene Collaborates with Presage to Evaluate Therapies with its CIVO Technology for Multiple Cancers

Celgene Collaborates with Presage to Evaluate Therapies with its CIVO Technology for Multiple Cancers

May 3, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us